LOXL3 and melanoma: Furthermore, suppression of LOXL3 expression enhances DNA damage signals within melanoma cells, leading not only to an increase in DNA double-strand breaks (DSB) and defects in G2/M phase progression, but also to reduced cellular apoptosis.